Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002089 · ClinicalTrials.gov registry record · NA
An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic Disseminated Mycobacterium Avium-Intracellulare Complex (MAC) Infection Failing Current Therapy
A NA study, sponsored by Pfizer.
- Completed
- Registry status
- NA
- Development phase
NCT00002089: Completed NA study, sponsored by Pfizer.
NCT00002089 is a NA study that has completed, run by Pfizer. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002089, a NA study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To evaluate the efficacy and safety of azithromycin given chronically for the treatment of Mycobacterium avium (MAC) bacteremia in patients failing or intolerant of current available MAC therapy.
Interventions
- DRUG Azithromycin
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002089 record still lists
NCT00002089 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Azithromycin is the first listed.
NCT00002089 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002089 about?
NCT00002089 is a clinical study titled "An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic Disseminated Mycobacterium Avium-Intracellulare Complex (MAC) Infection Failing Current Therapy". To evaluate the efficacy and safety of azithromycin given chronically for the treatment of Mycobacterium avium (MAC) bacteremia in patients failing or intolerant of current available MAC therapy.
What is the current status of trial NCT00002089?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002089?
The interventions under investigation include: Azithromycin (DRUG).
Who is sponsoring clinical trial NCT00002089?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.